NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Institute of Medicine (US) Roundtable on Value & Science-Driven Health Care; Yong PL, Olsen LA, McGinnis JM, editors. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation. Washington (DC): National Academies Press (US); 2010.

Cover of Value in Health Care

Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation.

Show details


For decades, the rise in healthcare costs in the United States has outpaced growth in the economy as a whole. The United States spends per capita on health almost double the average of other Organisation for Economic Co-operation and Development countries. Over the years, it has become increasingly clear that Americans are not gaining benefits commensurate with these higher expenditures: dozens of countries today boast superior life expectancy and lower infant mortality.

Among many efforts to enhance value from health expenditures, the Institute of Medicine in 2006 created a Roundtable on Evidence-Based Medicine, now called the Roundtable on Value & Science-Driven Health Care. Its purpose was to bring together patients and consumers, providers, manufacturers, payers, researchers and policy makers in a neutral venue to discuss ways evidence about how well interventions work could transform delivery of care in this country. The Roundtable developed a vision of a learning healthcare system where evidence is both applied and generated as a natural course of care. Building on this work, the Roundtable convened leaders, researchers, and policy makers from across the healthcare field on November 17–18, 2008, for the workshop Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation.

This volume summarizes the presentations and discussions from the workshop. These explore the meaning of value in health care from a variety of perspectives, present methods to measure value, and describe ways to give value-enhancing incentives to the provider, consumer, manufacturer, payer, and other stakeholders in the healthcare system. The insights and ideas shared in this volume are germane to the healthcare reform efforts currently ongoing in this country and, specifically, can help achieve the dual goals of controlling healthcare expenditures and improving health outcomes.

I would like to offer my thanks to the members of the Roundtable who champion better health for Americans, to the Roundtable staff who coordinate and enable Roundtable activities, and to the sponsors who support this vital activity: the Agency for Healthcare Research and Quality, America’s Health Insurance Plans, AstraZeneca, Blue Shield of California Foundation, Burroughs Wellcome Fund, California Health Care Foundation, Centers for Medicare and Medicaid Services, Department of Veterans Affairs, Food and Drug Administration, Johnson & Johnson, the Moore Foundation, the National Institutes of Health, sanofi-aventis, and Stryker.

Harvey V. Fineberg, M.D., Ph.D.

President, Institute of Medicine

Copyright © 2010, National Academy of Sciences.
Bookshelf ID: NBK50924
PubReader format: click here to try


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (2.2M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...